Royalty Pharma plc (RPRX)
NASDAQ: RPRX · IEX Real-Time Price · USD
27.27
-0.61 (-2.19%)
At close: May 17, 2024, 4:00 PM
27.56
+0.29 (1.06%)
After-hours: May 17, 2024, 7:15 PM EDT
Royalty Pharma Employees
Royalty Pharma had 89 employees on December 31, 2023. The number of employees increased by 14 or 18.67% compared to the previous year.
Employees
89
Change (1Y)
14
Growth (1Y)
18.67%
Revenue / Employee
$25,152,371
Profits / Employee
$8,975,921
Market Cap
12.31B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89 | 14 | 18.67% |
Dec 31, 2022 | 75 | 9 | 13.64% |
Dec 31, 2021 | 66 | 15 | 29.41% |
Dec 31, 2020 | 51 | 16 | 45.71% |
Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Tenet Healthcare | 106,500 |
DaVita | 70,000 |
Charles River Laboratories International | 21,800 |
Smith & Nephew | 19,081 |
Medpace Holdings | 5,900 |
Incyte | 2,524 |
ShockWave Medical | 1,468 |
RPRX News
- 5 days ago - Royalty Pharma to Present at Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab - GlobeNewsWire
- 16 days ago - Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma - Business Wire
- 4 weeks ago - Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 4 weeks ago - Royalty Pharma Declares Second Quarter 2024 Dividend - GlobeNewsWire
- 2 months ago - Royalty Pharma to Present at TD Cowen's 44th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Royalty Pharma Reports Q4 and Full Year 2023 Results - GlobeNewsWire
- 3 months ago - Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024 - GlobeNewsWire